RC
Ryan Cohlhepp (President, COO & Interim CEO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $785K of BCAX (27,139 sh across 2 lots, as filed), executed Jul 8. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Sep 8
Filed Sep 10
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
BCAXRecent filings
BCAXSALE
Bicara Therapeutics Inc.
View filing →
$144K8,000 sh × $18.05
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $145K
8,000 sh × $18.16
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $860K
47,600 sh across 3 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET